Marivel Rapee
Primary Care · Allentown, PANPI 1235870726
Payments from drug & device makers
Across 73 payments — averaging $24.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$604
- Sanofi-aventis U.S. LLC$311
- Lilly USA, LLC$203
- Medtronic$121
- AstraZeneca$95
- Novo Nordisk$79
- plus $387 from 13 others
What the payments were for
- Food & beverage$1,801100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 25 | $604 |
| Sanofi-aventis U.S. LLC | 4 | $311 |
| Lilly USA, LLC | 11 | $203 |
| Medtronic | 2 | $121 |
| AstraZeneca | 6 | $95 |
| Novo Nordisk | 4 | $79 |
| Johnson & Johnson | 3 | $63 |
| Phadia US Inc. | 2 | $57 |
| Pfizer | 3 | $55 |
| Xeris Pharmaceuticals, Inc. | 3 | $48 |
| E.r. Squibb & Sons, L.L.C. | 2 | $32 |
| Sunovion Pharmaceuticals Inc. | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Exact Sciences | 1 | $16 |
| Merck | 1 | $16 |
| Lexicon Pharmaceuticals, Inc. | 1 | $15 |
| Mannkind Corporation | 1 | $14 |
| Novartis | 1 | $13 |
| Amgen | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SOLIQUA 100/33$108
How this compares
$1,801 in reported general payments places this provider in the 75th percentile of 300 primary care providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 133 | $124,668 |
| TrulicityDulaglutide | 79 | $81,300 |
| OzempicSemaglutide | 62 | $60,738 |
| FarxigaDapagliflozin Propanediol | 71 | $54,780 |
| RybelsusSemaglutide | 36 | $44,045 |
| EliquisApixaban | 49 | $36,029 |
| JanuviaSitagliptin Phosphate | 35 | $28,512 |
| TradjentaLinagliptin | 23 | $16,254 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 21 | $12,468 |
| SynjardyEmpagliflozin/Metformin Hcl | 11 | $10,446 |
| Breo ElliptaFluticasone/Vilanterol | 16 | $8,997 |
| Advair HfaFluticasone Propion/Salmeterol | 19 | $7,475 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 81 | $7,132 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 110 | $2,848 |
| Atorvastatin Calcium | 236 | $2,721 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta, Synjardy | $604 | $151,368167 claims |
| Novo NordiskOzempic, Rybelsus | $79 | $104,78398 claims |
| Lilly USA, LLCTrulicity | $203 | $81,30079 claims |
| AstraZenecaFarxiga | $95 | $54,78071 claims |
| PfizerEliquis | $55 | $36,02949 claims |
| MerckJanuvia | $16 | $28,51235 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 300 primary care providers in Pennsylvania.
Other primary care in Allentown
- Kersten ReiderMount Penn$121K
- Teresa GiamboyPhiladelphia$21K
- Nicole IlgenfritzBethel Park$18K
- Galyna VorokhibPhiladelphia$12K
- Melissa BeansWarrington$12K
- Mollie McGuireJohnstown$11K
- Andrea MauriceNew Cumberland$11K
- Kendell SoglieroSmithfield$9K
- Minjung RegerDoylestown$9K
- Mackenzie HouserMedia$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.